4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000950170-25-075484
Chief Development Officer sold 32,262 shares at $74.17 ($2,393,014)
- Chief Development Officer acquired 32,262 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Guyer William Chief Development Officer | 2025-05-16 | Option exercise 10b5-1 | +32,262 | $21.65 | $698,472 | 37,749 | D |
| Guyer William Chief Development Officer | 2025-05-16 | Sale 10b5-1 | −32,262 | $74.17 | $2,393,014 | 5,487 | D |
| Derivatives | |||||||
| Guyer William Chief Development Officer | 2025-05-16 | Option exercise · Stock option (right to buy) 10b5-1 | −32,262 | 410,000 | D | ||
| Open-market sales · 32,262 sh · avg $74.17 · $2,393,014 | |||||||
Loading xslF345X05/ownership.xml…